podophyllotoxin has been researched along with Osteosarcoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, SC; Ji, JH; Kim, KY; Kim, SH; Kim, YW; Nam, HW; Park, SG; Son, KM; Suh, JT; Yu, SN | 1 |
Jin, S; Qi, SN; Yang, TM; Yang, YJ; Yuan, HQ; Zhang, B; Zhao, N | 1 |
Choy, E; Duan, Z; Harmon, D; Hornicek, FJ; Mankin, H; Ryu, K; Schwab, J; Yang, C | 1 |
Chen, CR; Guo, SF; Li, WG; Yang, TM; Zhang, XY | 1 |
4 other study(ies) available for podophyllotoxin and Osteosarcoma
Article | Year |
---|---|
Deoxypodophyllotoxin induces cytoprotective autophagy against apoptosis via inhibition of PI3K/AKT/mTOR pathway in osteosarcoma U2OS cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drugs, Chinese Herbal; Gene Expression Regulation; Humans; Osteosarcoma; Phosphoinositide-3 Kinase Inhibitors; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2017 |
Induction of apoptosis through caspase-independent or caspase-9-dependent pathway in mouse and human osteosarcoma cells by a new nitroxyl spin-labeled derivative of podophyllotoxin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 9; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Drug Therapy, Combination; Endodeoxyribonucleases; Etoposide; Humans; Mice; Osteosarcoma; Podophyllotoxin; Spin Labels | 2013 |
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Osteosarcoma; Podophyllotoxin; Protein Kinase Inhibitors; Receptor, IGF Type 1; RNA, Small Interfering | 2009 |
Anti-osteosarcoma effects and mechanisms of 4-O-amino-phenol-4'-demethylepipodophyllotoxin ether.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Calcium; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ethers; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Magnesium; Membrane Potential, Mitochondrial; Osteosarcoma; Podophyllotoxin; Reactive Oxygen Species; Time Factors | 2008 |